Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply

Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply

•Health equity stratifiers inform interpretations but do not imply generalizability.•Findings should be interpreted with relevant stakeholders or by diverse authorship.•Frameworks and guidelines exist to support researchers' inclusion of health equity.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical epidemiology 2024-07, Vol.171, p.111374, Article 111374
Hauptverfasser: Kou, Roger, Mbuagbaw, Lawrence
Format: Artikel
Sprache:eng
Schlagworte:
Authorship
COVID-19
COVID-19 vaccines
Ethnicity
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 111374
container_title Journal of clinical epidemiology
container_volume 171
creator Kou, Roger
Mbuagbaw, Lawrence
description •Health equity stratifiers inform interpretations but do not imply generalizability.•Findings should be interpreted with relevant stakeholders or by diverse authorship.•Frameworks and guidelines exist to support researchers' inclusion of health equity.
doi_str_mv 10.1016/j.jclinepi.2024.111374
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3050938893</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S089543562400129X</els_id><sourcerecordid>3050938893</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-6d70f34c14d49cb07fa16f2a8a95dd932a0199db1a63b7e61a4fdabc4ad52bda3</originalsourceid><addsrcrecordid>eNqFkM1O3DAURq0KpA5DX6GyxKabDHacODarVkMLSEhIiHbRjeXYNx1HIQ62gzQ7XoPX40nwaOiGDat7F-e7Pwehr5SsKKH8tF_1ZnAjTG5VkrJaUUpZU31CCyoaUdSypAdoQYSsi4rV_DM6irEnhDakqRfo7y1MPiQ3_sO-wxvQQ9pgeJhd2mLjx-gsBJ1c7rAb8aM2Jm_CKTg9RNz5gNc3f67OCyrPsJ7TxoeXp-eIA0zD9hgddpmCL291iX7_-nm3viyuby6u1j-uC8NKkgpuG9KxytDKVtK0pOk05V2phZa1tZKVmlApbUs1Z20DnOqqs7o1lbZ12VrNlujbfu4U_MMMMal7Fw0Mgx7Bz1ExUhPJhJAsoyfv0N7PYczXZUpwUYqak0zxPWWCjzFAp6bg7nXYKkrUTrnq1X_laqdc7ZXn4Pd9EPK7jw6CisbBaMC6ACYp691HI14BEJqOmA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3086828560</pqid></control><display><type>article</type><title>Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply</title><source>Elsevier ScienceDirect Journals</source><creator>Kou, Roger ; Mbuagbaw, Lawrence</creator><creatorcontrib>Kou, Roger ; Mbuagbaw, Lawrence</creatorcontrib><description>•Health equity stratifiers inform interpretations but do not imply generalizability.•Findings should be interpreted with relevant stakeholders or by diverse authorship.•Frameworks and guidelines exist to support researchers' inclusion of health equity.</description><identifier>ISSN: 0895-4356</identifier><identifier>ISSN: 1878-5921</identifier><identifier>EISSN: 1878-5921</identifier><identifier>DOI: 10.1016/j.jclinepi.2024.111374</identifier><language>eng</language><publisher>Elmsford: Elsevier Inc</publisher><subject>Authorship ; COVID-19 ; COVID-19 vaccines ; Ethnicity</subject><ispartof>Journal of clinical epidemiology, 2024-07, Vol.171, p.111374, Article 111374</ispartof><rights>2024 Elsevier Inc.</rights><rights>2024. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c320t-6d70f34c14d49cb07fa16f2a8a95dd932a0199db1a63b7e61a4fdabc4ad52bda3</cites><orcidid>0000-0002-0087-1012</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S089543562400129X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids></links><search><creatorcontrib>Kou, Roger</creatorcontrib><creatorcontrib>Mbuagbaw, Lawrence</creatorcontrib><title>Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply</title><title>Journal of clinical epidemiology</title><description>•Health equity stratifiers inform interpretations but do not imply generalizability.•Findings should be interpreted with relevant stakeholders or by diverse authorship.•Frameworks and guidelines exist to support researchers' inclusion of health equity.</description><subject>Authorship</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Ethnicity</subject><issn>0895-4356</issn><issn>1878-5921</issn><issn>1878-5921</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkM1O3DAURq0KpA5DX6GyxKabDHacODarVkMLSEhIiHbRjeXYNx1HIQ62gzQ7XoPX40nwaOiGDat7F-e7Pwehr5SsKKH8tF_1ZnAjTG5VkrJaUUpZU31CCyoaUdSypAdoQYSsi4rV_DM6irEnhDakqRfo7y1MPiQ3_sO-wxvQQ9pgeJhd2mLjx-gsBJ1c7rAb8aM2Jm_CKTg9RNz5gNc3f67OCyrPsJ7TxoeXp-eIA0zD9hgddpmCL291iX7_-nm3viyuby6u1j-uC8NKkgpuG9KxytDKVtK0pOk05V2phZa1tZKVmlApbUs1Z20DnOqqs7o1lbZ12VrNlujbfu4U_MMMMal7Fw0Mgx7Bz1ExUhPJhJAsoyfv0N7PYczXZUpwUYqak0zxPWWCjzFAp6bg7nXYKkrUTrnq1X_laqdc7ZXn4Pd9EPK7jw6CisbBaMC6ACYp691HI14BEJqOmA</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Kou, Roger</creator><creator>Mbuagbaw, Lawrence</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7T2</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0087-1012</orcidid></search><sort><creationdate>202407</creationdate><title>Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply</title><author>Kou, Roger ; Mbuagbaw, Lawrence</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-6d70f34c14d49cb07fa16f2a8a95dd932a0199db1a63b7e61a4fdabc4ad52bda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Authorship</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Ethnicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kou, Roger</creatorcontrib><creatorcontrib>Mbuagbaw, Lawrence</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kou, Roger</au><au>Mbuagbaw, Lawrence</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply</atitle><jtitle>Journal of clinical epidemiology</jtitle><date>2024-07</date><risdate>2024</risdate><volume>171</volume><spage>111374</spage><pages>111374-</pages><artnum>111374</artnum><issn>0895-4356</issn><issn>1878-5921</issn><eissn>1878-5921</eissn><abstract>•Health equity stratifiers inform interpretations but do not imply generalizability.•Findings should be interpreted with relevant stakeholders or by diverse authorship.•Frameworks and guidelines exist to support researchers' inclusion of health equity.</abstract><cop>Elmsford</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jclinepi.2024.111374</doi><orcidid>https://orcid.org/0000-0002-0087-1012</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0895-4356
ispartof Journal of clinical epidemiology, 2024-07, Vol.171, p.111374, Article 111374
issn 0895-4356
1878-5921
1878-5921
language eng
recordid cdi_proquest_miscellaneous_3050938893
source Elsevier ScienceDirect Journals
subjects Authorship
COVID-19
COVID-19 vaccines
Ethnicity
title Reporting of health equity considerations in vaccine trials for COVID-19: author’s reply
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T13%3A12%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reporting%20of%20health%20equity%20considerations%20in%20vaccine%20trials%20for%20COVID-19:%20author%E2%80%99s%20reply&rft.jtitle=Journal%20of%20clinical%20epidemiology&rft.au=Kou,%20Roger&rft.date=2024-07&rft.volume=171&rft.spage=111374&rft.pages=111374-&rft.artnum=111374&rft.issn=0895-4356&rft.eissn=1878-5921&rft_id=info:doi/10.1016/j.jclinepi.2024.111374&rft_dat=%3Cproquest_cross%3E3050938893%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3086828560&rft_id=info:pmid/&rft_els_id=S089543562400129X&rfr_iscdi=true